US stocks look set to open lower in Friday's trading session as investors parse GDP growth that fell short of analyst forecasts, and inflation data that rose slightly more than expected.

The Dow Jones Industrial Average futures were off 0.3%, S&P 500 futures declined 0.4%, and Nasdaq futures were 0.5% lower.

GDP growth decelerated much fast than expected, slowing to 1.4% from 4.4% in Q3, according to the US Bureau of Economic Analysis. Analysts polled by Bloomberg had forecast GDP growth of 2.8%.

Meanwhile, personal consumption expenditures rose by 2.4% in Q4, compared with a 3.5% gain in Q3, and met analyst forecasts, according to Bloomberg. Core PCE price growth slowed to 2.7% from 2.9%.

Oil prices were moving lower, with front-month global benchmarks North Sea Brent crude down 0.5% to $71.31 a barrel, and West Texas Intermediate crude declined 0.4% to $ 66.11 per barrel.

In other world markets, Japan's Nikkei dropped 1.1% and Hong Kong's Hang Seng also fell 1.1%. Meanwhile in Europe's early afternoon session, the UK's FTSE 100 was up 0.5%, Germany's DAX gained 0.3% and France's CAC increased 0.7%.

In equities, Opendoor Technologies (OPEN) shares were up nearly 17% Friday pre-bell, after the company reported overnight better-than-expected Q4 revenue.

RingCentral's (RNG) stock gained 14% after Morgan Stanley raised its price target on the stock to $33 from $30 a share.

Shares of Workiva (WK) climbed 13% after it reported Q4 earnings, and 2026 guidance that topped analyst forecasts.

On the losing side, Grail (GRAL) shares were over 44% lower in recent Friday premarket activity, a day after the company said its NHS-Galleri trial missed its primary Stage III and IV cancer reduction endpoint.

Chemours' (CC) stock was down more than 9%, a day after the company posted lower Q4 adjusted EPS and sales.

Hudbay Minerals (HBM) shares were 3% lower after the company reported lower-than-expected Q4 adjusted EPS and revenue.